- Wednesday 22 May 2013
- My Account
- Logout
- Register
- Login
- News
-
Voices
-
Find by writer
- Yasmin Alibhai-Brown
- Rebecca Armstrong
- Memphis Barker
- Terence Blacker
- Chris Blackhurst
- David Blanchflower
- Archie Bland
- Ian Burrell
- Andrew Buncombe
- Ben Chu
- Patrick Cockburn
- Laura Davis
- Mary Dejevsky
- Grace Dent
- Robert Fisk
- Andrew Grice
- Stefano Hatfield
- Philip Hensher
- Ian Herbert
- Howard Jacobson
- Ellen E Jones
- Alice Jones
- Owen Jones
- Simon Kelner
- Dominic Lawson
- Donald Macintyre
- Lisa Markwell
- Comment
- Campaigns
- Debate
- Editorials
- Letters
- IV Drip
- Archive
- Our Voices
- Commentators
- Columnists
- Democracy 2015
- IV Drip Archive
-
Find by writer
- Sport
- Tech
- Life
- Property
- Arts & Ents
- Travel
- Money
- IndyBest
- Blogs
- Student
The umbilical cord patent granted to Biocyte is one example of a growing trend by companies and universities now trying to patent cells, genetic sequences, plants, animals and human body parts which will have far reaching implications.
At least the patent granted to Biocyte Corporation can be challenged. However, if the directive on biotechnological inventions which is currently being considered by the European Parliament has its way, then it will be much more difficult to challenge this sort of ruling.
Monsanto has patented a soya bean seed that could in effect prevent other companies or NGOs working on soya bean seeds.
Du Pont has patented the onco-mouse - an important breakthrough in cancer treatment - in such a way that all similar work on any mammals or rodents will be barred.
Myriad Corporation have applied for a European patent on a linked breast and ovarian cancer susceptibility gene. This, if granted, would gain them control over all possible diagnostic and therapeutic applications of this gene. All cures for breast cancer would either have to be licensed by Myriad or royalties made payable to them.
The patent holder would have the power, for 20 years, to decide whether to allow further research and development, licensing the results. Or it would be able to deny the opportunity for any further work.
This patenting of the essence of life itself must not be allowed to pass unchallenged. The European Commission's proposals should be challenged by writing to MEPs.
SAM CLARKE
Oxford
-
Letters: Of course big business loves the EU
-
The so-called 'Robin Hood Tax' will rob pensioners and small businesses not just bankers
-
Ed Miliband is staring at an open goal and I know just the pair of strikers to win it for him
-
Never fall ill at a weekend - our out-of-hours health service is a disgrace
-
Poll: Does the fact that Boris Johnson has a love child change your opinion of the Mayor?
-
Internet porn is no kind of education, but LOLcats and Tumblr (almost) make up for it
Get your summer started with British Military Fitness
BMF is the UK’s biggest and best loved outdoor fitness classes
Visit York
Find out what The Independent's resident travel expert has to say about one of the most beautiful small cities in the world
Enter the latest Independent competitions
Win anything from gadgets to five-star holidays on our competitions and offers page.
Business videos from commercial thought leaders
Watch the best in the business world give their insights into the world of business.
Get the best in opinion from Independent Voices, straight to your inbox every Thursday lunchtime.
Subscribe
Amol Rajan
A weekly update from the Editor
iJobs General
Senior IP Associate / Partner - Manchester
Excellent Salary Package - £60K to £120K: Austen Lloyd: We have an exciting op...
Java Developer
£200 - £250 per day: Progressive Recruitment: Java Developer - Urgent Requirem...
BUSINESS INTELLIGENCE ARCHITECT, SAP
£70000 - £95000 per annum + Bonus, flexible working hours, remote work: Progre...
SAP BUSINESS INTELLIGENCE SENIOR CONSULTANT
£50000 - £56000 per annum + Benefits package, flexible working hours: Progress...
Day In a Page
Why clubs are keen to take a stand
In the end the fans decided Tony Pulis had made a pig's ear of the job at Stoke City
